Clinical Trials Directory

Trials / Unknown

UnknownNCT03587610

Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older

Evaluation of a Tdap-IPV Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older in the French County of Sarthe

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
402 (estimated)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

In France, vaccination coverage is insufficient (in 2002, 71.2% coverage for tetanus, 41.9% for poliomyelitis and 33.7% for diphteria). These numbers decrease significantly with age: coverage for people aged over 65 was 60.5%, 13.3% and 10.5% for tetanus, poliomyelitis and diphteria coverage respectively. The primary objective of this study is to evaluate the impact of a hospital based vaccination remedial strategy for Tdap-IPV (tetanus, diphteria, pertussis and polio vaccine) in patients 65 years of age or older. Secondary objectives are to measure the vaccination coverage of patients aged 65 years or older hospitalised in a medical ward in our hospital, to evaluate their knowledge of their vaccination coverage, and to evaluate the socio-demographic factors associated with vaccination coverage.

Conditions

Interventions

TypeNameDescription
BIOLOGICALRemedial vaccination* if the patients vaccinations are up to date: no remedial vaccination is done and the patient is informed of the next remedial vaccination date * if the patients vaccinations are not up to date: remedial vaccination is realised in the unit in the absence of contraindication, in case of a temporary contraindication the vaccination will be performed on an outpatient basis by the patients primary care provider and he will be given a prescription at hospital discharge for the remedial vaccination.

Timeline

Start date
2018-05-24
Primary completion
2019-11-01
Completion
2020-01-01
First posted
2018-07-16
Last updated
2019-01-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03587610. Inclusion in this directory is not an endorsement.